Ameriprise Financial Inc Supernus Pharmaceuticals, Inc. Transaction History

Ameriprise Financial Inc

  • $388 Billion
  • Q2 2025

A detailed history of Ameriprise Financial Inc transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 173,175 shares of SUPN stock, worth $7.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
173,175
Previous 452,684 61.74%
Holding current value
$7.14 Million
Previous $14.8 Million 63.18%
% of portfolio
0.0%
Previous 0.0%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$30.29 - $33.43 $8.47 Million - $9.34 Million
-279,509 Reduced 61.74%
173,175 $5.46 Million
Q1 2025

May 14, 2025
BUY
$31.17 - $40.0 $75,524 - $96,920
2,423 Added 0.54%
452,684 $14.8 Million
Q4 2024

Feb 14, 2025
SELL
$31.89 - $37.83 $3.05 Million - $3.62 Million
-95,794 Reduced 17.54%
450,261 $16.3 Million
Q3 2024

Nov 14, 2024
SELL
$25.77 - $35.16 $473,034 - $645,396
-18,356 Reduced 3.25%
546,055 $17 Million
Q2 2024

Aug 14, 2024
SELL
$25.99 - $33.85 $48,315 - $62,927
-1,859 Reduced 0.33%
564,411 $15.1 Million
Q1 2024

May 15, 2024
BUY
$27.11 - $35.17 $178,058 - $230,996
6,568 Added 1.17%
566,270 $19.3 Million
Q4 2023

Feb 14, 2024
SELL
$22.72 - $29.68 $211,682 - $276,528
-9,317 Reduced 1.64%
559,702 $16.2 Million
Q3 2023

Nov 14, 2023
SELL
$27.57 - $32.91 $722,499 - $862,439
-26,206 Reduced 4.4%
569,019 $15.7 Million
Q2 2023

Aug 14, 2023
SELL
$29.91 - $38.73 $2.5 Million - $3.24 Million
-83,614 Reduced 12.32%
595,225 $17.9 Million
Q1 2023

May 15, 2023
SELL
$34.93 - $42.03 $679,423 - $817,525
-19,451 Reduced 2.79%
678,839 $24.6 Million
Q4 2022

Feb 14, 2023
SELL
$31.09 - $37.88 $2.96 Million - $3.61 Million
-95,267 Reduced 12.01%
698,290 $24.9 Million
Q3 2022

Nov 14, 2022
SELL
$28.79 - $35.41 $906,971 - $1.12 Million
-31,503 Reduced 3.82%
793,557 $26.9 Million
Q2 2022

Aug 15, 2022
SELL
$25.33 - $34.25 $563,719 - $762,233
-22,255 Reduced 2.63%
825,060 $23.9 Million
Q1 2022

May 16, 2022
BUY
$28.51 - $32.9 $626,849 - $723,372
21,987 Added 2.66%
847,315 $27.4 Million
Q4 2021

Feb 14, 2022
SELL
$26.37 - $34.22 $374,190 - $485,581
-14,190 Reduced 1.69%
825,328 $24.1 Million
Q3 2021

Nov 15, 2021
BUY
$23.54 - $31.39 $853,960 - $1.14 Million
36,277 Added 4.52%
839,518 $22.4 Million
Q2 2021

Aug 16, 2021
BUY
$26.72 - $33.19 $1.02 Million - $1.27 Million
38,264 Added 5.0%
803,241 $24.7 Million
Q1 2021

May 17, 2021
BUY
$24.15 - $31.45 $239,640 - $312,078
9,923 Added 1.31%
764,977 $20 Million
Q4 2020

Feb 12, 2021
BUY
$17.7 - $25.81 $1.14 Million - $1.66 Million
64,316 Added 9.31%
755,054 $19 Million
Q3 2020

Nov 16, 2020
BUY
$20.2 - $25.05 $1.06 Million - $1.31 Million
52,493 Added 8.22%
690,738 $14.4 Million
Q2 2020

Aug 14, 2020
SELL
$17.09 - $24.89 $2.48 Million - $3.61 Million
-145,047 Reduced 18.52%
638,245 $15.2 Million
Q1 2020

May 15, 2020
BUY
$14.45 - $24.69 $336,439 - $574,857
23,283 Added 3.06%
783,292 $14.1 Million
Q4 2019

Feb 14, 2020
BUY
$19.93 - $29.13 $2.58 Million - $3.77 Million
129,434 Added 20.53%
760,009 $18 Million
Q3 2019

Nov 14, 2019
SELL
$25.47 - $33.37 $1.56 Million - $2.05 Million
-61,383 Reduced 8.87%
630,575 $17.3 Million
Q2 2019

Aug 14, 2019
BUY
$29.96 - $38.87 $7.45 Million - $9.66 Million
248,525 Added 56.05%
691,958 $22.9 Million
Q1 2019

May 15, 2019
SELL
$32.77 - $41.99 $1.19 Million - $1.53 Million
-36,404 Reduced 7.59%
443,433 $15.5 Million
Q4 2018

Feb 14, 2019
BUY
$30.84 - $49.51 $661,918 - $1.06 Million
21,463 Added 4.68%
479,837 $15.9 Million
Q3 2018

Nov 14, 2018
SELL
$42.7 - $56.55 $3.88 Million - $5.14 Million
-90,891 Reduced 16.55%
458,374 $23.1 Million
Q2 2018

Aug 14, 2018
SELL
$44.1 - $59.85 $1.77 Million - $2.4 Million
-40,170 Reduced 6.82%
549,265 $32.9 Million
Q1 2018

May 15, 2018
SELL
$37.15 - $46.9 $413,070 - $521,481
-11,119 Reduced 1.85%
589,435 $27 Million
Q4 2017

Feb 12, 2018
SELL
$36.4 - $42.6 $2.96 Million - $3.46 Million
-81,238 Reduced 11.92%
600,554 $23.9 Million
Q3 2017

Nov 07, 2017
BUY
$36.75 - $49.65 $25.1 Million - $33.9 Million
681,792
681,792 $27.3 Million

Others Institutions Holding SUPN

# of Institutions
311
Shares Held
61.6M
Call Options Held
11.4K
Put Options Held
0
View Full List

About SUPERNUS PHARMACEUTICALS, INC.

SUPN Quotes by TradingView
  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $2.21B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email